NCT02489019

Brief Summary

Hypotension is frequently encountered after induction of general anesthesia. It can be pronounced in elderly patients and can require administration of vasopressor agents including ephedrine and phenylephrine. Intraoperative hypotension, especially prolonged episodes, can contribute to an increase in morbidity and mortality in the postoperative period as suggested by some former studies. The investigators hypothesize that fentanyl can contribute to the decrease in blood pressure (BP) that is seen after induction of general anesthesia in older patients. This hypotension may be due to fentanyl blocking effect on the sympathetic nervous system. This study will be the first one to examine the effect of fentanyl administration on blood pressure in elderly patients with induction of general anesthesia prior to the start of surgery. If the study shows that fentanyl contributes to hypotension during this period, it may lead to a change in practice and better patient outcomes and mortality rates.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
105

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Feb 2018

Longer than P75 for phase_2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 1, 2015

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 2, 2015

Completed
2.6 years until next milestone

Study Start

First participant enrolled

February 19, 2018

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2020

Completed
2.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

June 5, 2019

Status Verified

June 1, 2019

Enrollment Period

2.4 years

First QC Date

July 1, 2015

Last Update Submit

June 4, 2019

Conditions

Keywords

AnesthesiaFentanylElderly

Outcome Measures

Primary Outcomes (1)

  • Development of hypotension

    Blood pressure will be recorded 60 minutes after administration of the study agent

    At 60 minutes following dose administration

Study Arms (3)

Control

PLACEBO COMPARATOR

Individuals assigned to this condition will receive 0.9 mcg/kg sodium chloride (NaCL)

Drug: Sodium chloride

Low Dose

EXPERIMENTAL

Individuals assigned to this condition will receive 1 mcg/kg fentanyl

Drug: Fentanyl

High Dose

EXPERIMENTAL

Individuals assigned to this condition will receive 2 mcg/kg fentanyl

Drug: Fentanyl

Interventions

Sodium chloride will be used as a placebo comparator in this trial

Also known as: NaCL
Control

Fentanyl is a synthetic opioid analgesic that will be used as the experimental intervention in this trial

Also known as: Actiq, Duragesic, Fentora, Sublimaze
High DoseLow Dose

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: 60 years and older
  • Patients coming from home (including those who will be admitted post-operatively)
  • Surgeries with general anesthesia alone or if combined with peripheral nerve blocks
  • Patients must be seen at the Russo operating room at Loyola Medical Center (Maywood, IL)

You may not qualify if:

  • Age less than 60
  • Patient refusal
  • Inpatient or emergency cases
  • Patients having combined general anesthesia and epidural anesthesia
  • Patients with a pre-induction mean arterial blood pressure (MAP) less than 50 or greater than 150
  • Patients who will receive rapid sequence induction with succinylcholine
  • Patients scheduled for cardiovascular surgery
  • Patients scheduled for inhalational induction
  • Patients with weight greater than 125 kg
  • Patients with a history of chronic opioid use

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Loyola University Medical Center

Maywood, Illinois, 60153, United States

RECRUITING

Related Publications (5)

  • Bijker JB, van Klei WA, Vergouwe Y, Eleveld DJ, van Wolfswinkel L, Moons KG, Kalkman CJ. Intraoperative hypotension and 1-year mortality after noncardiac surgery. Anesthesiology. 2009 Dec;111(6):1217-26. doi: 10.1097/ALN.0b013e3181c14930.

    PMID: 19934864BACKGROUND
  • Bijker JB, van Klei WA, Kappen TH, van Wolfswinkel L, Moons KG, Kalkman CJ. Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology. 2007 Aug;107(2):213-20. doi: 10.1097/01.anes.0000270724.40897.8e.

    PMID: 17667564BACKGROUND
  • Billard V, Moulla F, Bourgain JL, Megnigbeto A, Stanski DR. Hemodynamic response to induction and intubation. Propofol/fentanyl interaction. Anesthesiology. 1994 Dec;81(6):1384-93. doi: 10.1097/00000542-199412000-00013.

    PMID: 7992907BACKGROUND
  • Reich DL, Hossain S, Krol M, Baez B, Patel P, Bernstein A, Bodian CA. Predictors of hypotension after induction of general anesthesia. Anesth Analg. 2005 Sep;101(3):622-628. doi: 10.1213/01.ANE.0000175214.38450.91.

    PMID: 16115962BACKGROUND
  • Monk TG, Saini V, Weldon BC, Sigl JC. Anesthetic management and one-year mortality after noncardiac surgery. Anesth Analg. 2005 Jan;100(1):4-10. doi: 10.1213/01.ANE.0000147519.82841.5E.

    PMID: 15616043BACKGROUND

MeSH Terms

Conditions

Hypotension

Interventions

Sodium ChlorideFentanyl

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

ChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium CompoundsPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Officials

  • Jeffrey Hartwig, MD

    Loyola University Chicago

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jeffrey Hartwig, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 1, 2015

First Posted

July 2, 2015

Study Start

February 19, 2018

Primary Completion

July 1, 2020

Study Completion

December 1, 2022

Last Updated

June 5, 2019

Record last verified: 2019-06

Data Sharing

IPD Sharing
Will not share

Locations